ENGOLCE
Mitsubishi Tanabe Pharma Corporation
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98257831 |
| Attorney Name | A. Tally Eitan |
| Attorney Docket Number | T-80184-US |
Timeline
| 2023-11-07 | Application Filed |
| 2023-11-10 | Location: NEW APPLICATION PROCESSING |
| 2023-11-10 | Status: Live/Pending |
| 2023-11-10 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Mitsubishi Tanabe Pharma Corporation |
| Address | 3-2-10, Dosho-machi, Chuo-ku, Osaka-shi JP JAPAN541- |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260103 | Circles, incomplete (more than semi |
| 260106 | Circles, semi; Semi |
| 260117 | Circles, two concentric; Concentric circles, two; Two concentric circles |
| 270301 | Geometric figures forming letters, numerals or punctuation |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| DM0000 | The mark consists of ENGOLCE with fading circles to the left of the letter E. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2023-11-10 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-12-04 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2023-12-05 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2024-03-05 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-03-08 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-03-08 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-03-08 | 7 GNRN O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2024-03-10 | 8 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-03-10 | 9 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-03-10 | 10 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-03-14 | 11 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-03-14 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-03-14 | 13 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-03-14 | 14 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-04-03 | 15 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2024-04-23 | 16 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-04-23 | 17 NPUB E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ENGOLCE 98257831 not registered Live/Pending |
Mitsubishi Tanabe Pharma Corporation 2023-11-07 |
 ENGOLCE 98041497 not registered Live/Pending |
Mitsubishi Tanabe Pharma Corporation 2023-06-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 